Interdisziplinäre Arbeitsgruppe Nierenzellkarzinom – IAG-N: Studien
| Nierenzellkarzinom, 1st-line |
||||
| AIO-assoziierte Studie | für weitere Zentren offen | www.clinicaltrials.gov | zur Studie | |
| AIO-NZK-0117/ass: A Phase 2, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated and Advanced (unresectable or metastatic) non-clear Cell Renal Cell Carcinoma (SUNNIFORECAST) | ||||
| ---in Rekrutierung--- | ||||
| AIO-assoziierte Studie | für weitere Zentren offen |
www.clinicaltrials.gov | zur Studie | |
| AIO-NZK-0115: A phase III study testing the role of proactive coaching on patient reported outcome in metastatic renal cell carcinoma treated with sunitinib [PREPARE] Artikel zur PREPARE-Studie im FORUM Juni 2017 |
||||
| ---in Rekrutierung--- | ||||
| Fortgeschrittenes Nierenzellkarzinom |
||||
| AIO-assoziierte Studie | www.pei.de | zur Studie | ||
| AIO-NZK-0118/ass: Cabozantinib in adult patients with advanced renal cell carcinoma following prior systemic check point inhibition therapy: a retrospective, non-interventional study (CaboCHECK) | ||||
| ---in Rekrutierung--- | ||||
|
LETZTE AKTUALISIERUNG DIESER SEITE AM: 27.10.2020 |